ATE223212T1 - Conagenine zur prävention und behandlung von diarrhöe - Google Patents

Conagenine zur prävention und behandlung von diarrhöe

Info

Publication number
ATE223212T1
ATE223212T1 AT95934300T AT95934300T ATE223212T1 AT E223212 T1 ATE223212 T1 AT E223212T1 AT 95934300 T AT95934300 T AT 95934300T AT 95934300 T AT95934300 T AT 95934300T AT E223212 T1 ATE223212 T1 AT E223212T1
Authority
AT
Austria
Prior art keywords
diarrhea
conagenins
prevention
treatment
cancer
Prior art date
Application number
AT95934300T
Other languages
English (en)
Inventor
Masaaki Ishizuka
Kenji Maeda
Tomio Takeuchi
Toshiyuki Toko
Tadayoshi Shiraishi
Original Assignee
Zaidan Hojin Biseibutsu
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zaidan Hojin Biseibutsu, Taiho Pharmaceutical Co Ltd filed Critical Zaidan Hojin Biseibutsu
Application granted granted Critical
Publication of ATE223212T1 publication Critical patent/ATE223212T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Chemical Treatment Of Metals (AREA)
AT95934300T 1994-10-14 1995-10-13 Conagenine zur prävention und behandlung von diarrhöe ATE223212T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24946694 1994-10-14
JP20820195A JP4078397B2 (ja) 1994-10-14 1995-08-15 下痢の予防及び治療剤
PCT/JP1995/002107 WO1996011681A1 (fr) 1994-10-14 1995-10-13 Antidiarrheique therapeutique et preventif

Publications (1)

Publication Number Publication Date
ATE223212T1 true ATE223212T1 (de) 2002-09-15

Family

ID=26516699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95934300T ATE223212T1 (de) 1994-10-14 1995-10-13 Conagenine zur prävention und behandlung von diarrhöe

Country Status (9)

Country Link
US (1) US5952380A (de)
EP (1) EP0783884B1 (de)
JP (1) JP4078397B2 (de)
KR (1) KR100369890B1 (de)
AT (1) ATE223212T1 (de)
AU (1) AU691674B2 (de)
CA (1) CA2202389A1 (de)
DE (1) DE69528068T2 (de)
WO (1) WO1996011681A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4078397B2 (ja) * 1994-10-14 2008-04-23 財団法人微生物化学研究会 下痢の予防及び治療剤
JP4019158B2 (ja) * 1997-04-09 2007-12-12 財団法人微生物化学研究会 潰瘍性大腸炎及び／又はクローン病の予防及び治療剤
JPWO2007011066A1 (ja) * 2005-07-22 2009-02-05 株式会社カネカ 繊維芽細胞賦活剤、コラーゲン産生促進剤、コラーゲン収縮促進剤、ヒアルロン酸産生促進剤、ａｔｐ産生促進剤、メラニン生成抑制剤、皮膚外用剤
CN110714050A (zh) * 2018-07-13 2020-01-21 永州职业技术学院 一种基于多种微生物的急性毒性试验方法及其试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2837870B2 (ja) * 1989-05-23 1998-12-16 財団法人微生物化学研究会 新規な制癌抗生物質コナゲニン及びその製造法
JPH04112865A (ja) * 1990-09-03 1992-04-14 Dainippon Pharmaceut Co Ltd 置換アミド誘導体
JPH0798752B2 (ja) * 1991-08-09 1995-10-25 株式会社ツムラ β−グルクロニダーゼ阻害剤
JPH0665072A (ja) * 1992-08-17 1994-03-08 Microbial Chem Res Found 化学療法剤及び又は放射線による副作用の軽減剤
JP4078397B2 (ja) * 1994-10-14 2008-04-23 財団法人微生物化学研究会 下痢の予防及び治療剤

Also Published As

Publication number Publication date
AU3673795A (en) 1996-05-06
EP0783884A4 (de) 1999-06-23
KR100369890B1 (ko) 2003-05-12
DE69528068T2 (de) 2003-10-02
KR970705987A (ko) 1997-11-03
US5952380A (en) 1999-09-14
JPH08165236A (ja) 1996-06-25
DE69528068D1 (de) 2002-10-10
JP4078397B2 (ja) 2008-04-23
EP0783884A1 (de) 1997-07-16
AU691674B2 (en) 1998-05-21
EP0783884B1 (de) 2002-09-04
WO1996011681A1 (fr) 1996-04-25
CA2202389A1 (en) 1996-04-25

Similar Documents

Publication Publication Date Title
KR920019342A (ko) 골질환 치료제
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
ATE359074T1 (de) Raloxifene in der behandlung von postmeopausal osteoporose
ATE142489T1 (de) Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
DE3875866T2 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
DE69500673T2 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
ATE139440T1 (de) Behandlung von entzündlichen darmerkrankungen
ATE223212T1 (de) Conagenine zur prävention und behandlung von diarrhöe
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
SE9001308D0 (sv) Foerfarande foer att behandla och foerebygga foertvining av bensubstans
AU3401093A (en) Therapeutic agent for threatened abortion
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
DE69005909D1 (de) Mischung von Vitamin A in physiologischer Dosis und verschiedenen Wirkstoffen mit therapeutischer Wirksamkeit.
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
KR930702016A (ko) 골다공증 치료제
ATE464051T1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
WO2000002578A8 (fr) Remedes contre les maladies liees a l'apoptose
CA2197139A1 (en) A drug for the treatment of cancer
KR930019216A (ko) 종양 치료제
DE3772047D1 (de) Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.
RU95104302A (ru) Аппликационный материал лечебно-профилактического назначения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties